SCHEMBL14309671

SCHEMBL14309671

CC1c2cnccc2CCc2c(F)cccc21

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.38
▸ CHRNA4 P43681 2/20 0.38
▸ KDM4C Q9H3R0 3/20 0.38
▸ CYP19A1 P11511 2/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ CHRNA7 P36544 1/20 0.35
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ FDPS P14324 1/20 0.33
▸ DRD2 P14416 1/20 0.32
▸ DRD3 P35462 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6385324 0.83 CYP19A1 (0.40) CHRNB2CHRNA4KDM4CCYP19A1CYP11B1
SCHEMBL18067714 0.81 DRD2 (0.39) CHRNB2CHRNA4CHRNA7DRD2DRD3
SCHEMBL6387593 0.77 KDM4C (0.34) CHRNB2CHRNA4KDM4CCYP19A1CYP11B1
SCHEMBL14303286 0.75 HTR2A (0.45) CHRNB2CHRNA4KDM4CCYP19A1CYP11B1
SCHEMBL6388506 0.71 ADRA2A (0.44) CHRNB2CHRNA4CYP19A1CYP11B1CYP11B2
SCHEMBL13343950 0.70 HTR2A (0.43) CHRNB2CHRNA4CYP19A1CYP11B1CYP11B2
SCHEMBL6391832 0.67 CYP11B1 (0.44) KDM4CCYP19A1CYP11B1CYP11B2ADRA2A
SCHEMBL6391836 0.67 CYP11B1 (0.44) KDM4CCYP19A1CYP11B1CYP11B2ADRA2A
SCHEMBL6388288 0.67 CYP19A1 (0.47) CYP19A1CYP11B1CYP11B2
SCHEMBL6384474 0.66 ADRA2A (0.39) CHRNB2CHRNA4CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458684-B1 THERAPEUTIC HETEROCYCLES AS BRADYKININ B2 RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2008-01-16 — — EP disclosed
Send feedback